Download fulltext HTML
1.
P Lambat S, B Nangia V, V Nangia P, H Shah N, D Mishra S. Krill’s Disease: A Newer Management Option. JOVR [Internet]. 2023Jul.23 [cited 2024May15];18(3):334–338. Available from: https://knepublishing.com/index.php/JOVR/article/view/13782

https://doi.org/10.18502/jovr.v18i3.13782

statistics

  • 526 Abstract Views
  • 359 PDF Views
  • 0 HTML Views
  • Cited by 1 article

authors

  • Sarang P Lambat

    Sarang P Lambat

    Vitreoretinal Services, Suraj Eye Institute, Nagpur, India
  • Vinay B Nangia

    Vinay B Nangia

    Vitreoretinal Services, Suraj Eye Institute, Nagpur, India
  • Prabhat V Nangia

    Prabhat V Nangia

    Cornea and Refractive Services, Suraj Eye Institute, Nagpur, India
  • Neha H Shah

    Neha H Shah

    Vitreoretinal Services, Suraj Eye Institute, Nagpur, India
  • Swati D Mishra

    Swati D Mishra

    Vitreoretinal Services, Suraj Eye Institute, Nagpur, India

Published Date

  • Jul 23, 2023
This journal is publishing all the articles under Creative Commons Attribution License CC BY 4.0.

Krill’s Disease: A Newer Management Option

Journal of Ophthalmic and Vision Research (JOVR) / July–September 2023, Volume 18, Issue 3 / Pages 334–338

Abstract

Purpose: To report a case of a young female who presented with scotoma in the right eye for few days.


Case Report: Krill’s disease or acute retinal pigment epithelitis (ARPE) is a self-limiting retinal disease with no specific treatment. Typical clinical and imaging features helped us to diagnose her with ARPE. Intravenous methylprednisolone (IVMP), which gives a rapid anti-inflammatory response, was advised. An SD-OCT scan post-injection showed a reduction in hyperreflectivity and height of lesion at day 3 and near total resolution by day 5.


Conclusion: This case suggests rapid resolution of ARPE with the use of IVMP

Keywords:

Acute Retinal Pigment Epithelitis; Intravenous Methylprednisolone; Krill’s Disease

References
1. Cho HJ, Han SY, Cho SW, Lee DW, Lee TG, Kim CG, et al. Acute retinal pigment epitheliitis: Spectral-domain optical coherence tomography findings in 18 cases. Invest Ophthalmol Vis Sci 2014;55:3314–3319.

2. Baillif S, Wolff B, Paoli V, Gastaud P, Mauget-Faÿsse M. Retinal fluorescein and indocyanine green angiography and spectral-domain optical coherence tomography findings in acute retinal pigment epitheliitis. Retina 2011;31:1156–1163.

3. Iu LP, Lee R, Fan MC, Lam WC, Chang RT, Wong IY. Serial spectral-domain optical coherence tomography findings in acute retinal pigment epitheliitis and the correlation to visual acuity. Ophthalmology 2017;124:903–909.

4. Deutman AF. Acute retinal pigment epitheliitis. Am J Ophthalmol 1974;78:571–578.

5. Quillen DA, Zurlo JJ, Cunningham D, Blankenship GW. Acute retinal pigment epitheliitis and hepatitis C. Am J Ophthalmol 1994;118:120–121.

6. Gilhotra JS, Gilhotra AK, Holdaway IM, Donaldson ML. Acute retinal pigment epitheliitis associated with intravenous bisphosphonate. Br J Ophthalmol 2006;90:798–799.

7. Dhami A, Malhi RK, Dhami NB, Dhami GS. Acute retinal pigment epithelitis: Optical coherence tomography-based diagnostic approach. Indian J Ophthalmol 2020;68:913– 914.

8. Toker E, Kazokoğlu H, Acar N. High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet’s disease. Br J Ophthalmol 2002;86:521–523.